A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis

被引：0
|
作者：
Christine K. Bailey
Stephen Caltabiano
Alexander R. Cobitz
Chun Huang
Kelly M. Mahar
Vickas V. Patel
机构：
[1] R&D,
[2] Clinical Sciences,undefined
[3] GlaxoSmithKline,undefined
[4] R&D,undefined
[5] GlaxoSmithKline,undefined
[6] R&D,undefined
[7] Clinical Statistics,undefined
[8] GlaxoSmithKline,undefined
[9] R&D,undefined
[10] Clinical Pharmacology,undefined
[11] Modeling and Simulation,undefined
[12] GlaxoSmithKline,undefined
[13] R&D,undefined
[14] Discovery Medicine,undefined
[15] GlaxoSmithKline,undefined
来源：
BMC Nephrology | / 20卷
关键词：
Anemia; Hemodialysis; Three-times weekly (TIW); Dose response; Bayesian; Efficacy; Clinical trials; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 24 条
  • [1] A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis
    Bailey, Christine K.
    Caltabiano, Stephen
    Cobitz, Alexander R.
    Huang, Chun
    Mahar, Kelly M.
    Patel, Vickas V.
    BMC NEPHROLOGY, 2019, 20 (01)
  • [2] Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial
    Coyne, Daniel W.
    Singh, Ajay K.
    Lopes, Renato D.
    Bailey, Christine K.
    DiMino, Tara L.
    Huang, Chun
    Connaire, Jeffrey
    Rastogi, Anjay
    Kim, Sung-Gyun
    Orias, Marcelo
    Shah, Sapna
    Patel, Vickas
    Cobitz, Alexander R.
    Wanner, Christoph
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (09): : 1325 - 1336
  • [3] Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia A Randomized, Double-Blind, Phase 3 Trial
    Akizawa, Tadao
    Nangaku, Masaomi
    Yonekawa, Taeko
    Okuda, Nobuhiko
    Kawamatsu, Shinya
    Onoue, Tomohiro
    Endo, Yukihiro
    Hara, Katsutoshi
    Cobitz, Alexander R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (08): : 1155 - 1165
  • [4] Safety and Efficacy of Vadadustat Once Daily and Three Times Weekly in Patients With Dialysis-Dependent CKD With Anemia
    Kooienga, Laura
    Burke, Steven
    Kathresal, Amarnath
    Luo, Wenli
    Yang, Zhihui
    Zhang, Zhiqun
    Zwiech, Rafal
    Hernandez, German T.
    KIDNEY360, 2024, 5 (11): : 1652 - 1661
  • [5] Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER)
    Kerwin, Edward
    Feldman, Gregory
    Pearle, James
    De La Cruz, Luis
    Edwards, Melinda
    Beaudot, Carolyn
    Georges, George
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 18 (02) : 181 - 190
  • [6] Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study
    Oakes, Tina Marie Myers
    Skljarevski, Vladimir
    Zhang, Qi
    Kielbasa, William
    Hodsdon, Michael E.
    Detke, Holland C.
    Camporeale, Angelo
    Saper, Joel R.
    CEPHALALGIA, 2018, 38 (06) : 1015 - 1025
  • [7] Efficacy and Safety of Indacaterol, a New 24-hour 2-Agonist, in Patients with Asthma: A Dose-Ranging Study
    Kanniess, Frank
    Boulet, Louis-Philippe
    Pierzchala, Wladyslaw
    Cameron, Ray
    Owen, Roger
    Higgins, Mark
    JOURNAL OF ASTHMA, 2008, 45 (10) : 887 - 892
  • [8] Tolerability, safety, and efficacy of a novel phosphate binder VS-505 (AP301): a Phase 2 dose-escalation and dose-ranging study in patients undergoing maintenance hemodialysis
    Zhuang, Bing
    Gan, Liangying
    Liu, Bin
    Yuan, Weijie
    Shi, Ming
    Peng, Ai
    Wang, Lihua
    Chen, Xiaolan
    Liu, Tongqiang
    Zhang, Shiying
    Wang, Song
    Gao, Qing
    Wang, Baoxing
    Zheng, Huixiao
    Liu, Changhua
    Luo, Yuan
    Ye, Hong
    Lin, Hongli
    Li, Yiwen
    He, Qiang
    Zheng, Feng
    Luo, Ping
    Long, Gang
    Lu, Wei
    LI, Kanghui
    Yang, Junwei
    Liu, Yingxue Cathy
    Zhang, Zhizheng
    Li, Xiaoling
    Zhang, Weifeng
    Zuo, Li
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (10) : 1649 - 1661
  • [9] Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6-to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
    Provenzano, Robert
    Besarab, Anatole
    Wright, Steven
    Dua, Sohan
    Zeig, Steven
    Nguyen, Peter
    Poole, Lona
    Saikali, Khalil G.
    Saha, Gopal
    Hemmerich, Stefan
    Szczech, Lynda
    Yu, K. H. Peony
    Neff, Thomas B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (06) : 912 - 924
  • [10] A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia
    Connor, Kathryn M.
    Mahoney, Erin
    Jackson, Saheeda
    Hutzelmann, Jill
    Zhao, Xin
    Jia, Nan
    Snyder, Ellen
    Snavely, Duane
    Michelson, David
    Roth, Thomas
    Herring, W. Joseph
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (08):
123